Drug Pipeline

ABSK021 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05804045 Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) Tenosynovial Giant Cell Tumor Active, Not Recruiting
Phase 2
NCT07499362 Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT)… Tenosynovial Giant Cell Tumor Recruiting
Phase 1
NCT04192344 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients… Neoplasms Recruiting
Sponsors Running ABSK021 Trials
Abbisko Therapeutics Co, Ltd (2) Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)
Get alerts when ABSK021 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free